Literature DB >> 29872948

Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.

B Voellger1,2, N Waldt3, Rosita Rupa4,5, E Kirches3, O Melhem4, H-J Ochel6, C Mawrin3, R Firsching4.   

Abstract

OBJECTIVE: Resveratrol and radiation decrease viability in various tumor cells. This study aims to investigate combined effects of resveratrol and radiation on viability, induction of apoptosis and necrosis, and expression of apoptosis modulators in rodent GH3 and TtT/GF pituitary adenoma cells in vitro.
METHODS: Cells were incubated with 10-100 µM resveratrol. Medium and medium with ethanol served as controls. After 2 h, cells were irradiated with 0-5 Gray (Gy) and further incubated for 48-72 h. Cell viability was quantified using a hemocytometer. Cell death was assessed with an enzyme-linked immunosorbent assay (ELISA) that detects free nucleosomes in cell lysates and free nucleosomes released to the culture medium. Expression of B-cell lymphoma-2 protein (BCL-2) and BCL-2 associated Xprotein (BAX) was measured using quantitative real time-polymerase chain reaction (qRT-PCR) to analyze changes in BAX/BCL-2 ratio.
RESULTS: Resveratrol and irradiation with 4 Gy alone and in combination significantly decreased cell viability (p = 0.017 and less). In the ELISA, 10 μM resveratrol significantly induced apoptosis in TtT/GF cells at 0 Gy (p < 0.001), but not at 3 or 5 Gy. In the ELISA, 10 μM resveratrol significantly induced necrosis in GH3 cells at 0, 3 and 5 Gy (p < 0.001). While qRT-PCR did not demonstrate a significant effect of 10 µM resveratrol or radiation on expression of BAX or BCL-2, a significant increase in the BAX/BCL-2 ratio was found after irradiation with 5 Gy in GH3 cells (p = 0.0027).
CONCLUSION: While moderate irradiation solely led to inhibited proliferation, resveratrol induced cell death in rodent pituitary adenoma cells.

Entities:  

Keywords:  Cell death; GH3; Radiation; Resveratrol; TtT/GF

Mesh:

Substances:

Year:  2018        PMID: 29872948     DOI: 10.1007/s11060-018-2918-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.

Authors:  Ann I McCormack; John A H Wass; Ashley B Grossman
Journal:  Eur J Clin Invest       Date:  2011-04-18       Impact factor: 4.686

2.  Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.

Authors:  Lei Cao; Hua Gao; Songbai Gui; Giwei Bai; Runchun Lu; Fei Wang; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2014-01-10       Impact factor: 4.130

Review 3.  Chemosensitization of tumors by resveratrol.

Authors:  Subash C Gupta; Ramaswamy Kannappan; Simone Reuter; Ji Hye Kim; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

4.  The prosurvival role of autophagy in resveratrol-induced cytotoxicity in GH3 cells.

Authors:  Xuexin Zhang; Wanhai Xu; Jun Su; Ming Chu; Hua Jin; Guofu Li; Chunlei Tan; Xin Wang; Chao Wang
Journal:  Int J Mol Med       Date:  2014-02-17       Impact factor: 4.101

5.  Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells.

Authors:  Xi Lin; Gang Wu; Wen-Qian Huo; Yao Zhang; Feng-Shuo Jin
Journal:  Int J Urol       Date:  2012-05-21       Impact factor: 3.369

6.  Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury.

Authors:  M K Jones; O R Padilla; E Zhu
Journal:  J Physiol Pharmacol       Date:  2010-06       Impact factor: 3.011

7.  Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis.

Authors:  Yujiang Fang; Vincent G DeMarco; Michael B Nicholl
Journal:  Cancer Sci       Date:  2012-04-15       Impact factor: 6.716

Review 8.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

Authors:  Mohammad Athar; Jung Ho Back; Levy Kopelovich; David R Bickers; Arianna L Kim
Journal:  Arch Biochem Biophys       Date:  2009-06-15       Impact factor: 4.013

9.  Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.

Authors:  S Y Lee; B T Ahn; S H Baik; B L Lee
Journal:  Neurosurgery       Date:  1998-07       Impact factor: 4.654

10.  Chromatophagy: autophagy goes nuclear and captures broken chromatin during arginine-starvation.

Authors:  Hsing-Jien Kung; Chun A Changou; Chien-Feng Li; David K Ann
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

View more
  4 in total

Review 1.  Common tools for pituitary adenomas research: cell lines and primary cells.

Authors:  Ziyan Zhu; Weiwei Cui; Dimin Zhu; Nailin Gao; Yonghong Zhu
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

2.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

Review 3.  Targeting Aggressive Pituitary Adenomas at the Molecular Level-A Review.

Authors:  Benjamin Voellger; Zhuo Zhang; Julia Benzel; Junwen Wang; Ting Lei; Christopher Nimsky; Jörg-Walter Bartsch
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.241

4.  Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT-20 and TtT/GF by affecting expression of MMP-14 and ADAM12.

Authors:  Zhuo Zhang; Jörg W Bartsch; Julia Benzel; Ting Lei; Christopher Nimsky; Benjamin Voellger
Journal:  FEBS Open Bio       Date:  2020-10-26       Impact factor: 2.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.